Navigation Links
Cell study offers more diabetic patients chance of transplant

Diabetic patients could benefit from a breakthrough that enables scientists to take cells from the pancreas and change their function to produce insulin.

The research could reduce waiting times for patients with Type 1 Diabetes who need islet cell transplants. These transplants are carried out to prevent life-threatening complications resulting from diabetes, such as seizures resulting from low blood sugar levels.

Islet cells -- which occur naturally in the pancreas -- produce insulin, which enables the body to store glucose. However, not enough of these cells can be provided by a single donor for a successful islet transplant to take place.

This means that patients can wait months before a second pancreas becomes available so that a sufficient number of islet cells to be transplanted.

The breakthrough, published in the journal Diabetes, could enable pancreatic cells -- other than islets -- to be developed in the laboratory for transplant operations.

It was carried out by the University of Aberdeen, the Medical Research Council Centre for Regenerative Medicine at the University of Edinburgh and the Scottish National Blood Transfusion Service.

Only one pancreas donation would be needed to enable the successful transplantation of insulin-producing cells, which would save months waiting for a second donor to become available as well as make more organs available for other patients

This would involve an islet cell transplant once an organ becomes available, followed by a second transplant soon after when enough pancreatic cells have been developed to produce insulin.

The effects of the operations would also be longer lasting than currently as more cells would be transplanted.

Islet cell transplants are given to Type 1 diabetics -- who are unable to make insulin and are dependent on insulin injections -- to treat severe hypoglycemic unawareness.

This condition can cause potentially fatal seizures as patients have no warning signals that their blood sugar has reached dangerously low levels.

Almost 20 per cent of patients with Type 1 diabetes suffer from hypoglycemic unawareness.

John Casey, of the University of Edinburgh and also lead clinician for the National Islet Transplant Programme in Scotland, said: "There is a shortage of organ donors, which is not helped by the need for two pancreases to be donated to treat each patient. Developing previously unusable cells to produce insulin means that fewer donors would be needed, which would make a huge difference to patients waiting for transplants operations."

The research was funded by the Medical Research Council.

Professor Kevin Docherty, of the University of Aberdeen, said: "This is an example of how reprogramming, -- the ability to change one cell type into another -- can have a huge impact on the development of cell based therapy for diabetes and many other diseases."

An islet cell transplant programme was introduced in the UK in 2008. Since then, over 90 islet transplants have been successfully carried out in the UK with some patients now completely free of insulin injections.


Contact: Tara Womersley
University of Edinburgh

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. Law that regulates shark fishery is too liberal: UBC study
3. New study will help protect vulnerable birds from impacts of climate change
4. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
5. BYU study: Using a gun in bear encounters doesnt make you safer
6. 15-year study: When it comes to creating wetlands, Mother Nature is in charge
7. Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
8. Crystal structure of archael chromatin clarified in new study
9. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
10. University of Houston study shows BP oil spill hurt marshes, but recovery possible
11. Study demonstrates cells can acquire new functions through transcriptional regulatory network
Post Your Comments:
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology: